O-Tricyclo[5.2.1.02,6]dec-9-yl dithiocarbonate potassium salt
CAS: 83373-60-8
Ref. 3D-IDA37360
1mg | 163,00 € | ||
5mg | 310,00 € | ||
10mg | 436,00 € | ||
25mg | 647,00 € | ||
50mg | 986,00 € |
Información del producto
- Carbonodithioic acid, O-(octahydro-4,7-methano-1H-inden-5-yl) ester, potassium salt
- Carbonodithioic acid, O-(octahydro-4,7-methano-1H-inden-5-yl) ester, potassium salt (1:1)
- D 609
- O-(Octahydro-4,7-methano-1H-inden-5-yl)carbonodithioate potassium salt
- O-(octahydro-1H-4,7-methanoinden-5-yl) hydrogen carbonodithioate
- Potassium O-(octahydro-4,7-methano-1H-inden-5-yl) carbonodithioate (1:1)
- Tricyclo-decan-9-yl-xanthate
- Tricyclodecane-9-yl-xanthogenate
- potassium O-(octahydro-1H-4,7-methanoinden-5-yl) dithiocarbonate
O-Tricyclo[5.2.1.02,6]dec-9-yl dithiocarbonate potassium salt (OTCDK) is a cytosolic calcium ionophore that activates soluble guanylate cyclase (sGC). This activation leads to an increase in intracellular levels of cGMP and thereby the production of nitric oxide (NO). OTCDK has been shown to inhibit the synthesis of prostanoids by inhibiting the activity of enzymes such as phospholipase A2 and COX-2 that are responsible for the conversion of arachidonic acid to prostaglandins. This drug also inhibits bladder contractility and relaxes muscle, which may be due to its ability to inhibit calcium influx into cells. OTCDK has been shown to induce relaxation in isolated arteries and reduce atherosclerotic lesion size in mice. The concentration-response curve for OTCDK was found to be steepest
Propiedades químicas
Consulta técnica sobre: 3D-IDA37360 O-Tricyclo[5.2.1.02,6]dec-9-yl dithiocarbonate potassium salt
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.